SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
SEC Accession No. 0001193125-12-287782
Filing Date
2012-06-28
Accepted
2012-06-28 16:27:42
Documents
10
Period of Report
2012-03-31
Filing Date Changed
2012-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d363672d20f.htm 20-F 1026191
2 CERTIFICATION OF THE INTERIM CEO PURSUANT TO SECTION 302 d363672dex121.htm EX-12.1 9714
3 CERTIFICATION OF THE INTERIM CFO PURSUANT TO SECTION 302 d363672dex122.htm EX-12.2 9713
4 CERT.OF INTERIM CEO AND GROUP VP, INTERIM CFO PURSUANT TO 18 U.S.C.SECTION 1350 d363672dex13.htm EX-13 6189
  Complete submission text file 0001193125-12-287782.txt   4728083

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT taro-20120331.xml EX-101.INS 823809
6 XBRL TAXONOMY EXTENSION SCHEMA taro-20120331.xsd EX-101.SCH 22641
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE taro-20120331_cal.xml EX-101.CAL 47283
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE taro-20120331_def.xml EX-101.DEF 21172
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE taro-20120331_lab.xml EX-101.LAB 191513
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE taro-20120331_pre.xml EX-101.PRE 117814
Mailing Address THREE SKYLINE DR HAWTHORNE NY 10532
Business Address 14 HAKTOR ST HAIFA BAY L3 26110 9143459001
TARO PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000906338 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-35463 | Film No.: 12932906
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1